Rafael Rosengarten

CEO at Genialis Inc., USA

Speaker

Rafael Rosengarten, CEO of Genialis, leads the company’s effort to deliver the next generation of clinical biomarkers to help the right patient get the right treatment at the right time. He spent nearly 20 years in biomedical research prior to Genialis, publishing in the fields of evolution, immunology, bioengineering and genetics. Dr. Rosengarten is also a board member and co-founder of the Alliance for AI in Healthcare (AAIH). Rafael attended Dartmouth College and then Yale University, where he was an NSF Graduate Research Fellow. He went on to postdoctoral training in Jay Keasling’s synthetic biology group at Lawrence Berkeley National Laboratory, Joint BioEnergy Institute (JBEI), where he co-invented the j5 DNA assembly design automation tool (which has since been commercialized by TeselaGen Biotechnology). This was followed by a National Library of Medicine fellowship in Biomedical Informatics at Baylor College of Medicine. In his free time, Rafael enjoys cooking, climbing mountains, and exploring the world with his wife and two precocious children.